1. Others

Others

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73917):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-123695
    5-HT4 antagonist 3 148702-58-3 98%
    5-HT4 antagonist 3 is an active compound.
    5-HT4 antagonist 3
  • HY-123706
    Salinosporamide C 863126-96-9 98%
    Salinosporamide C (compound 4) is a decarboxylated pyrrole analog. Salinosporamide C is the secondary metabolite of the obligate marine actinomycete Salinispora tropical.
    Salinosporamide C
  • HY-123708
    SNAP 398299 903878-06-8 98%
    SNAP 398299 is a Gal3 receptor antagonist with potential anxiolytic and antidepressant effects. SNAP 398299 can partially reverse the neuropeptide Galanin-induced inhibition of dorsal raphe cell firing and the Galanin-induced hyperpolarizing current.
    SNAP 398299
  • HY-123710
    GYKI-16084 185739-21-3 98%
    GYKI-16084 is a new compound that can be isolated from dog and rat urine. GYKI-16084 can be used in the research of benign prostatic hyperplasia.
    GYKI-16084
  • HY-123712
    2α,17α-Diethynyl-A-nor-5α-androstane-2β,17β-diol diacetate 70226-89-0 98%
    2α,17α-Diethynyl-A-nor-5α-androstane-2β,17β-diol diacetate is an active compound.
    2α,17α-Diethynyl-A-nor-5α-androstane-2β,17β-diol diacetate
  • HY-123718
    6-Benzylthioinosine 6165-03-3 98%
    6-Benzylthioinosine is a compound with antileukemic activity that increases cytotoxicity against acute myeloid leukemia cells when combined with metformin, modulating cellular metabolism and signaling pathways through multiple mechanisms.
    6-Benzylthioinosine
  • HY-123723
    Hydroxystreptomycin 6835-00-3 98%
    Hydroxystreptomycin is an active compound.
    Hydroxystreptomycin
  • HY-123724
    Ravidomycin 74622-75-6 98%
    Ravidomycin is a compound with antibacterial and cytotoxic activities. New analogs have been isolated from microorganisms. These analogs differ in antibacterial selectivity compared with known compounds.
    Ravidomycin
  • HY-123733
    MIP-1095 949575-22-8 98%
    MIP-1095 potently inhibits the glutamate carboxypeptidase activity of PSMA (Ki =0.24 nM).
    MIP-1095
  • HY-123734
    S-75 37764-44-6 98%
    S-75 is a potential radiation shielding agent.
    S-75
  • HY-123736
    Ro 32-7315 219613-02-2 98%
    Ro 32-7315 is a TNF-α converting enzyme (TACE) inhibitor.
    Ro 32-7315
  • HY-123759
    sEH-IN-12 1883803-09-5 98%
    sEH-IN-12 is a potent soluble epoxide hydrolase (sEH) inhibitor with the property of inhibiting sEH activity. sEH-IN-12 was successfully used in the construction and selection of small molecule libraries, showing excellent biological activity. The development of sEH-IN-12 provides a new tool for drug discovery targeting sEH.
    sEH-IN-12
  • HY-123882
    IRAK4-IN-29 1604034-78-7 98%
    IRAK4-IN-29 is an IRAK4 inhibitor with good selectivity and low nanomolar activity. IRAK4-IN-29 can effectively block the TLR-mediated signal transduction pathway. IRAK4-IN-29 showed significant inhibitory effects in LPS- and R848-induced cytokine experiments. IRAK4-IN-29 can inhibit LPS-induced TNFα in an in vivo model, showing a similar phenotype to IRAK4 gene-deficient mice. IRAK4-IN-29 has good medicinal chemical properties, such as microsomal stability and solubility, showing potential clinical application value.
    IRAK4-IN-29
  • HY-123895
    Tanshindiol A 97411-46-6 98%
    Tanshindiol A is a natural product.
    Tanshindiol A
  • HY-12394S1
    Dothiepin-d6 hydrochloride 1276545-35-7 98%
    Dothiepin-d6 (hydrochloride) is the deuterium labeled Dothiepin hydrochloride.
    Dothiepin-d6 hydrochloride
  • HY-124002
    4-Hydroxyalternariol 959417-21-1 98%
    4-Hydroxyalternariol is an Alternaria metabolite.
    4-Hydroxyalternariol
  • HY-124009R
    L-Cysteic acid (Standard) 498-40-8 98%
    L-Cysteic acid (Standard) is the analytical standard of L-Cysteic acid. This product is intended for research and analytical applications. L-Cysteic acid is the oxidation product of L-cystine. L-Cysteic acid is a substrate of GADCase/CADCaseII. L-Cysteic acid has high affinity with CADCase I (Km = 0.22 mM). L-Cysteic acid is taken up by the synaptosome through a high affinity, Na+-dependent transport system.
    L-Cysteic acid (Standard)
  • HY-124021
    Benzyl 2-naphthyl ether 613-62-7 99.44%
    Benzyl 2-naphthyl ether is a compound mentioned in the study of the effects of aromatic sensitizers on zebrafish embryos. It can cause morphological abnormalities and changes in gene expression in zebrafish embryos. Its toxicity mechanism is partly related to AHR, and there may be other mechanisms independent of AHR.
    Benzyl 2-naphthyl ether
  • HY-124022
    HDAC-IN-69 676599-90-9 98%
    HDAC-IN-69 (Compound 2) is a derivative of an HDAC inhibitor with inhibitory activity targeting maize histone deacetylase HD2.
    HDAC-IN-69
  • HY-124050
    Echimidine 520-68-3 98%
    Echimidine ((+)-Echimidine) is the major alkaloid detected in the honey used to produce the mead.
    Echimidine